Viral Vector Development
& Manufacturing 

Accelerate your CGT’s journey from lab to patient.

With an increasing number of companies exploring niches in the CGT sector, the demand for specialized development and manufacturing of viral vectors is surging. At the core of this scientific shift is the need for highly specific vector expertise – as unique as the therapies you develop. There is no universal blueprint; your work deserves a custom-crafted strategy to bring life-saving therapies to those in need swiftly and safely.

Partnering with Us, You Accelerate Your Path to Market

In viral vector development, the journey from concept to clinical application demands a combination of scientific know-how and commercial experience — core expertise in the professionals working at NecstGen. We facilitate your translational journey within a state-of-the-art, GMP-compliant development and manufacturing facility, ensuring that your project adheres to the highest standards from the outset.

Our team is adept at crafting tailored process designs, meticulously designed to meet the distinct needs of your therapy. We are well-versed in the nuances of scaling up production to clinically relevant volumes, an essential step to meet increasing demand while maintaining the integrity of your product.

Lentiviruses (LV)
Ideal for stable gene delivery, with a track record of safety and efficacy.

Adeno-associated viruses (AAV)
The vector of choice for targeting various tissues with minimal immune response.

Oncolytic viruses
Harnessing the power of virotherapy to selectively target and destroy cancer cells.

Continuity Though Product Development

Our commitment to scalability spans every trial phase in viral vector manufacturing, ensuring you can access state-of-the-art production capabilities when it matters most. From the crucial early stages of pre-clinical studies or toxicology material production, NecstGen provides robust support in developing and manufacturing viral vectors.

As your therapy progresses, we ensure the transition from one phase to the next is seamless, providing reliable and high-quality viral vector supplies from Phase I to Phase III clinical trials.

This continuity is the bedrock of our service—guaranteeing not just consistency in the product but also confidence in the process, allowing our scientific partners to focus on the pivotal task of advancing their therapies through the trial phases toward ultimate regulatory approval and patient application.

Watch Replay

Product Quality For Cell Therapies

Our experts can provide insights and answer your queries to advance your cell therapy development. This webinar is designed to help you explore and navigate the complexities of product quality strategies for cell therapies, but if you have additional questions, we invite you to ask us your questions.

Cell Therapy Manufacturing & Development

Viral Vector Manufacturing & Development

Cleanroom Rental